StreetAlpha.app
Home › Stocks › INFU

InfuSystem Holdings, Inc (INFU)

$14.35
▲ +2.06%
LAST CLOSE · NOV 20

InfuSystem Holdings supplies infusion pumps and home healthcare services to oncology clinics and other healthcare providers. It last closed at $14.35 on Nov 20, up 2.06% on the day. The next earnings report for INFU is expected around Tue, Feb 23, 2027. For the quarter ended Sep 2026, INFU reported EPS of $0.15 on revenue of $37.6M, with revenue up 3.0% from a year ago. Over its last 8 reports the stock moved an average of 12.6% the session after earnings. Over the last 12 months INFU insiders bought $150K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is INFU in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold INFU.

Key Stats

Last 12 months
Results
Revenue
$144.4M
+2.4% vs a year ago
Net income
$9.4M
+70.9% vs a year ago
EPS (diluted)
$0.44
+69.2% vs a year ago
Free cash flow
$24.8M
17.1% margin
Valuation
Market cap
$287.5M
20.0M shares
P/E
32.6
Price over 12 month EPS
Price to sales
2.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$9.1M
At Sep 30
Debt
$19.7M
At Sep 30
Shareholder equity
$64.2M
Buybacks
$6.3M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $102.4M$102.4MFY2021FY2022: $109.9M$109.9MFY2022FY2023: $125.8M$125.8MFY2023FY2024: $134.9M$134.9MFY2024FY2025: $143.4M$143.4MFY2025

From INFU's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Feb 23
Estimated date · Time not announced
Reported EPS
$0.15
Quarter ended Sep 2026
Year ago EPS
$0.11
+36.4% on a GAAP basis
Revenue
$37.6M
+3.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.04Dec '24Mar 2025: -$0.01Mar '25Jun 2025: $0.12Jun '25Sep 2025: $0.11Sep '25Dec 2025: $0.09Dec '25Mar 2026: $0.05Mar '26Jun 2026: $0.15Jun '26Sep 2026: $0.15Sep '26Latest $0.15
Revenue by quarter
Dec 2024: $33.8MDec '24Mar 2025: $34.7MMar '25Jun 2025: $36.0MJun '25Sep 2025: $36.5MSep '25Dec 2025: $36.2MDec '25Mar 2026: $33.7MMar '26Jun 2026: $36.9MJun '26Sep 2026: $37.6MSep '26Latest $37.6M
How INFU moved after its last 8 reports
Average move the session after a report ±12.6%
Nov 5, 2026Time not announced+3.1%
Aug 4, 2026Time not announced+33.6%
May 7, 2026Time not announced−11.5%
Feb 24, 2026Time not announced+13.5%
Nov 4, 2025Time not announced−9.0%
Aug 5, 2025Time not announced+3.8%
May 8, 2025Time not announced+15.2%
Mar 4, 2025Time not announced−10.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on INFUStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on INFU
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on INFU

Technical Analysis

INFU · as of the Nov 20 close · updated each morning
Uptrend

The stock is 1% above its 20 day and 5% above its 50 day average. It is 25% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 53). The nearest support is the 20 day average at $14.25, and the nearest resistance the swing high (Oct 22) at $14.41.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 4.4%/day
Key levels
$15.4752 week high+7.8%
$14.61Pivot R1+1.8%
$14.41Swing high (Oct 22)+0.4%
$14.35Last close
$14.2520 day average−0.7%
$14.19Pivot−1.1%
$13.93Pivot S1−2.9%
$13.6350 day average−5.0%
$13.43Swing low (Oct 28)−6.4%
$12.28100 day average−14.4%
$10.78200 day average−24.9%
$7.2952 week low−49.2%
Indicators
RSI (14)52.92Middle of its rangeNeutral
MACD0.28Below its signal lineBearish
Stochastic64.6Middle of its rangeNeutral
ADX (14)19.1No clear trend
Williams %R-35.7Oversold below −80, overbought above −20Neutral
CCI (20)-7.7Oversold below −100, overbought above 100Neutral
Rate of change+4.8%Change over 10 sessionsBullish
ATR (14)$0.63Typical daily range, 4.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for INFU

What happened before

See how INFU did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow INFU usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How INFU has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for INFUHow many large options trades hit INFU, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

INFU Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲72 buying vs 38 selling
  • ▲Held by funds +5.7 pts
  • ▲Funds holding +21
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding121100+21.0%
In funds' top 10110.0%
Held by funds84.3%78.6%+5.7 pts
New / increased30 / 4225 / 27+38.5%
Reduced / sold out29 / 926 / 22−20.8%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See INFU institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

INFU Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$150K4 buys · 3 insiders
Sold$00 sales · 0 insiders
Cluster buy: 3 insiders bought $131K between May 8 and May 11.
2026-03 bought $19K2026-05 bought $131KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
May 11Carrie LachancePresident and CEOBuy3,000$8.71$26K
May 8Barry G SteeleExecutive VP and CFOBuy7,000$8.71$61K
May 8Paul Andrew GendronDirectorBuy5,000$8.88$44K
Mar 2Barry G SteeleExecutive VP and CFOBuy2,064$9.16$19K
Aug 22, 2025Scott ShudaDirectorSale5,752$9.67$56K
May 28, 2025Kenneth D. EichenbaumDirectorBuy2,000$5.18$10K
Every insider buy and sale for INFU over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See INFU insider trades →

From SEC Form 4 filings by INFU's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INFU is in one of them and how their past INFU trades turned out.

INFU in the AI portfolios
Loading…

INFU News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered INFU in an article yet. Here's the latest on the wider market.

INFU in the news

About InfuSystem Holdings

InfuSystem Holdings provides home healthcare equipment and services from its base in Rochester Hills, Michigan. Its main business supplies electronic infusion pumps and disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics, mainly for chemotherapy given over time to patients at home. The company also handles equipment delivery, billing, nursing support and biomedical repair, and it rents and sells pumps, wound care devices and related supplies to hospitals, surgery centers and other healthcare providers.

Headquarters
Rochester Hills, MI